共 4 条
[1]
prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular disease in man. Mizushima Y,Yanagawa A,Hoshi K,et al. Journal of Pharmacokinetics and Pharmacodynamics . 1983
[2]
The effect of prostaglandin E1 alpha CD on vibratory threshold determined with the SMV-5 vibrometer in patients with diabetic neuropathy. Shindo H,Tawata M,Inoue M,et al. Diabetes Research and Clinical Practice . 1994
[3]
Prostaglandins.[P]. DALMADI GYULA[HU];HERMECZ ISTVAN[HU];IVANICS JOZSEF[HU];IVANICS JOZSEFNE[HU];KOVACS GABORNE[HU];SZAB TIBOR[HU];BAHRAM RESUL[SE].EP0544899A1,1993-06-09
[4]
Intravenous prostaglandin E1 in severe peripheral vascular disease. Carlson LA,Olsson AG. The Lancet . 1976